Results 21 to 30 of about 604,032 (210)

Risk Factors and Pathogenic Mechanism for Secondary Primary Lung Cancer 
in Breast Cancer Patients: A Review

open access: yesChinese Journal of Lung Cancer, 2022
Breast cancer and lung cancer are the two most common malignancies in China. With the continuous improvement of breast cancer diagnosis and treatment technology, the survival time of breast cancer patients has been prolonged, and the number of breast ...
Di CHEN, Yaolai XIAO, Kaize ZHONG
doaj   +1 more source

Investigation of Second Primary Lung Malignancy Rates in Laryngeal Cancer Patients

open access: yesB-ENT
Background: Laryngeal cancer (LC) accounts for 30-40% of head and neck malignancies and is the most common malignancy in the field of otolaryngology.
Esra Bozkurt Hatipoğlu   +5 more
doaj   +3 more sources

Clinical characteristics and risk of second primary lung cancer after cervical cancer: A population-based study.

open access: yesPLoS ONE, 2020
BackgroundLung cancer is increasingly common as a second primary malignancy. However, the clinical characteristics of second primary non-small cell lung cancer after cervical cancer (CC-NSCLC) compared with first primary non-small cell lung cancer ...
Chengyuan Qian   +6 more
doaj   +1 more source

Therapeutic method for early-stage second primary non-small lung cancer: analysis of a population-based database

open access: yesBMC Cancer, 2021
Background Early-stage non-small lung cancer patients may survive long enough to develop second primary lung cancers. However, few studies have accurately described the therapeutic method, evaluation or prognostic factors for long-term survival in this ...
Congcong Chen   +8 more
doaj   +1 more source

Second primary tumor after immune checkpoint inhibitor therapy: A case report

open access: yesThoracic Cancer, 2022
Immune checkpoint inhibitors (ICIs) are used to treat many types of cancers. However, the effect of ICIs on second primary tumors is still unclear. Some studied have concluded that ICIs could reduce the incidence of second primary tumors, while others ...
Kang Miao   +4 more
doaj   +1 more source

Synchronous Malignancies Identified by PET-CT Scan in Breast Cancer Patients

open access: yesRambam Maimonides Medical Journal, 2022
Breast cancer is a common malignancy and a common cause of cancer-related mortality in women. Pre-treatment workup of breast cancer does not routinely include positron emission tomography scans.
Maya Paran   +3 more
doaj   +1 more source

The genomic and transcriptome characteristics of lung adenocarcinoma patients with previous breast cancer

open access: yesBMC Cancer, 2022
Background Breast cancer and lung cancer are the top two malignancies in the female population and the number of patients with breast cancer and subsequent primary lung cancer has increased significantly in recent years.
Yan Wang   +8 more
doaj   +1 more source

The long-term outcomes of metachronous tumors for non-small cell lung cancer

open access: yesClinical Surgical Oncology
Background: We aimed to identify prognostic factors for mortality and survival in patients operated on for metachronous primary lung cancer (MPLC).
Celalettin Kocaturk   +6 more
doaj   +1 more source

Surgery for lung cancer as the second primary malignancy

open access: yesActa Medica Lituanica, 2013
Following a successful treatment of the first oncological disease, the second malignancy can develop. This retrospective study was designed to evaluate the efficacy of surgical treatment results for patients with the second primary lung cancer (2PLC ...
Arnoldas Krasauskas   +4 more
doaj   +1 more source

Risk of second primary Cancer among bladder Cancer patients: a population-based cohort study in Korea

open access: yesBMC Cancer, 2018
Background For the expanding population of bladder cancer survivors in Korea, the development of subsequent cancers is a significant concern. Here, we provide the second primary cancer incidence rates and types in Korean patients with bladder cancer ...
Whi-An Kwon   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy